Paul Newhouse
Last active: 3/3/2020

Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.

Vega JN, Dumas J, Newhouse PA
Am J Geriatr Psychiatry. 2017 25 (12): 1415-1426

PMID: 28495470 · PMCID: PMC5630507 · DOI:10.1016/j.jagp.2017.04.001

Advances in cancer treatment are producing a growing number of cancer survivors; therefore, issues surrounding quality of life during and following cancer treatment have become increasingly important. Chemotherapy-related cognitive impairment (CRCI) is a problem that is commonly reported following the administration of chemotherapy treatment in patients with cancer. Research suggests that CRCI can persist for months to years after completing treatment, which has implications for the trajectory of normal and pathologic cognitive aging for the growing number of long-term cancer survivors. These problems are particularly relevant for older individuals, given that cancer is largely a disease of older age, and the number of patients with cancer who are aged 65 years or older will increase dramatically over the coming decades. This review will briefly summarize empirical findings related to CRCI, discuss CRCI in older patients with cancer, propose potential causative hypotheses, and provide a canonical patient case to illustrate how CRCI presents clinically. Finally, potential intervention strategies for CRCI will be highlighted and issues to consider when evaluating older patients with a history of cancer will be discussed.

Copyright © 2017 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

MeSH Terms (5)

Aged Aging Cognitive Dysfunction Humans Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: